PDF
0.58
MB

Utilizing A-TEEM Technology for In-Process Monitoring of Monoclonal Antibody Production
In this paper, HORIBA presents evaluation work from CPI showing A-TEEM as a suitable technique to analyze six in-process manufacturing samples of monoclonal antibodies. This work is an initial step toward implementing this technique as a PAT solution in biologics manufacturing.

